<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57870</article-id><article-id pub-id-type="doi">10.7554/eLife.57870</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>High-resolution structures of multiple 5-HT<sub>3A</sub>R-setron complexes reveal a novel mechanism of competitive inhibition</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-76969"><name><surname>Basak</surname><given-names>Sandip</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184277"><name><surname>Kumar</surname><given-names>Arvind</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8421-8669</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184278"><name><surname>Ramsey</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184279"><name><surname>Gibbs</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184280"><name><surname>Kapoor</surname><given-names>Abhijeet</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3606-3463</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-50740"><name><surname>Filizola</surname><given-names>Marta</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-70039"><name><surname>Chakrapani</surname><given-names>Sudha</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0722-2338</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Physiology and Biophysics</institution>, <institution>Case Western Reserve University</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pharmacological Sciences</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">2Department of Pharmacological Sciences</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-64899"><name><surname>Czajkowski</surname><given-names>Cynthia M</given-names></name><role>Reviewing editor</role><aff><institution>University of Wisconsin, Madison</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>Sudha.chakrapani@case.edu</email> (SC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>16</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e57870</elocation-id><history><date date-type="received"><day>15</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Basak et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Basak et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57870-v1.pdf"/><abstract><p>Serotonin receptors (5-HT<sub>3A</sub>R) play a crucial role in regulating gut movement, and are the principal target of setrons, a class of high-affinity competitive antagonists, used in the management of nausea and vomiting associated with radiation and chemotherapies. Structural insights into setron-binding poses and their inhibitory mechanisms are just beginning to emerge. Here, we present high-resolution cryo-EM structures of full-length 5-HT<sub>3A</sub>R in complex with palonosetron, ondansetron, and alosetron. Molecular dynamic simulations of these structures embedded in a fully-hydrated lipid environment assessed the stability of ligand-binding poses and drug-target interactions over time. Together with simulation results of apo- and serotonin-bound 5-HT<sub>3A</sub>R, the study reveals a distinct interaction fingerprint between the various setrons and binding-pocket residues that may underlie their diverse affinities. In addition, varying degrees of conformational change in the setron-5-HT<sub>3A</sub>R structures, throughout the channel and particularly along the channel activation pathway, suggests a novel mechanism of competitive inhibition.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM108921,R01GM131216,R35GM134896</award-id><principal-award-recipient><name><surname>Chakrapani</surname><given-names>Sudha</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>17POST33671152</award-id><principal-award-recipient><name><surname>Basak</surname><given-names>Sandip</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>20POST35210394</award-id><principal-award-recipient><name><surname>Kumar</surname><given-names>Arvind</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sandip Basak</collab><collab>Sudha Chakrapani</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of 5HT3A receptor in presence of Alosetron</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6W1J">http://www.rcsb.org/structure/6W1J</ext-link><comment>Protein Data Bank, 6W1J</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sandip Basak</collab><collab>Sudha Chakrapani</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of 5HT3A receptor in presence of Ondansetron</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6W1M">http://www.rcsb.org/structure/6W1M</ext-link><comment>Protein Data Bank, 6W1M</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Sandip Basak</collab><collab>Sudha Chakrapani</collab></person-group><year iso-8601-date="2020">2020</year><source>Cryo-EM structure of 5HT3A receptor in presence of Palonosetron</source><ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/structure/6W1Y">http://www.rcsb.org/structure/6W1Y</ext-link><comment>Protein Data Bank, 6W1Y</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Basak S</collab><collab>Chakrapani S</collab></person-group><year iso-8601-date="2019">2019</year><source>https://www.rcsb.org</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6NP0">https://www.rcsb.org/structure/6NP0</ext-link><comment>Protein Data Bank, 6NP0</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Zarkadas E</collab><collab>Zhang H</collab><collab>Cai W</collab><collab>Effantin G</collab><collab>Perot J</collab><collab>Neyton J</collab><collab>Chipot C</collab><collab>Schoehn G</collab><collab>Dehez F</collab><collab>Nury H</collab></person-group><year iso-8601-date="2020">2020</year><source>Mouse serotonin 5HT3 receptor in complex with palonosetron</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/6Y1Z">https://www.rcsb.org/structure/6Y1Z</ext-link><comment>Protein Data Bank, 6Y1Z</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-57870-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>